Iradimed price to book ratio IRMD

Market value divided by the book value of the company's net assets, since 2014.

Today, Oct 23, 2026: 10.8×
10-year median: 6.7×
Against its 10-year history: 91st; percentile: 0 is its lowest day, 100 its highest
10-year range: 2.8× to 13.5×
Peer median: 2.9×

Iradimed's price to book ratio is 10.8× as of Oct 23, 2026.

That is above its ten-year median of 6.7×, higher than on 91% of days in the last ten years.

Over that time it ranged from 2.8× in Jun 2017 to 13.5× in Mar 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 2.9×.

Price to book ratio over time

median 6.7×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	10.8×	10.3×	13.5×
2025	12.6×	7.2×	12.6×
2024	8.3×	7.0×	8.6×
2023	8.0×	5.4×	9.9×
2022	5.1×	5.0×	9.0×
2021	8.4×	4.5×	8.4×
2020	4.6×	3.5×	6.1×
2019	5.5×	4.5×	7.7×
2018	6.3×	4.3×	11.0×
2017	5.0×	2.8×	5.0×
2016	3.9×	3.2×	9.7×
2015	11.0×	6.8×	14.0×
2014	6.8×	4.3×	16.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest Iradimed's size, closest first, today.

Company	Price to book ratio
IRMDIradimed	10.8×
STAAStaar Surgical	3.1×
BVSBioventus	5.5×
CDRECadre	3.7×
EYENational Vision	1.6×
MOVMovado	1.4×
LMATLemaitre Vascular	4.6×
INSPInspire Medical Systems	2.5×
MDXGMimedx	2.6×
TCMDTactile Systems Technology	2.4×
UFPTUFP Technologies	5.0×
Peer median	2.9×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Iradimed

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.